InvestorsHub Logo
Followers 9
Posts 358
Boards Moderated 0
Alias Born 09/08/2017

Re: None

Tuesday, 04/14/2020 10:13:31 PM

Tuesday, April 14, 2020 10:13:31 PM

Post# of 16700
See this is slightly confusing to me. Why is Algernon paying companies for exposure or to get their name out if they are on the verge of human trials for COVID 19? I feel as though what they are doing and what they are currently bringing to the table is substantial enough to garner enough attention on its own. Why pay for promo? Maybe I am missing something here.

Also CEO Chris Moreau mentioned that they are receiving emails from 3rd party companies asking them if they require funding. I'm assuming grants of some kind. So if they are getting offers by the same merit should they not need to be paying for additional marketing within the pharmaceutical realm. The volume clearly indicates people are starting to take notice. Any thoughts on this?